About Entrez
Text Version
Entrez PubMed
Overview
Help |
FAQ
Tutorial
New/Noteworthy
E-Utilities
PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
Special Queries
LinkOut
My NCBI
(Cubby)
Related Resources
Order Documents
NLM Catalog
NLM Gateway
TOXNET
Consumer Health
Clinical Alerts
ClinicalTrials.gov
PubMed Central
|
|
| Display Show |
 |
Items 1 - 8 of 8 |
One page. |
Rate of tardive dyskinesia in hospitalized patients.
Ross DE, Thomas M, Booth M, Weinborn M.
Publication Types:
PMID: 15800173 [PubMed - indexed for MEDLINE]
-
Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine.
Matsumoto R, Kitabayashi Y, Nakatomi Y, Tsuchida H, Fukui K.
Publication Types:
PMID: 15800166 [PubMed - indexed for MEDLINE]
-
Liepmann's phenomenon during benzodiazepine withdrawal.
Saito M, Matsui Y, Otani Y, Miyaoka H.
Publication Types:
PMID: 15800165 [PubMed - indexed for MEDLINE]
-
Neurotoxicity associated with free valproic acid.
Mayerhoff DI, Nurenberg J, Shah S, Schleifer SJ.
Publication Types:
PMID: 15800163 [PubMed - indexed for MEDLINE]
Systemic immediate allergic reactions to arthropod stings and bites.
Bircher AJ.
Allergy Unit, Department of Dermatology, University Hospital Basel, Basel, Switzerland. andreas.bircher@unibas.ch
Most of the encounters with biting and stinging insects result in more or less pronounced localized reactions. Typically, urticarial wheals and papular reactions are observed. Less often local bullous or hemorrhagic or disseminated papular reactions, particularly in children and immunologically naive adults, may be seen. With the exception of bee and wasp venom allergies, immediate-type allergic reactions to arthropod stings and bites are rare. Systemic IgE-mediated hypersensitivity has also been reported from additional hymenoptera species, e.g. hornets, bumble bees and ants. Rare are systemic reactions to mosquitoes, flies or kissing bugs and exceptional from ticks, bed bugs, moths, caterpillars and spiders. A major problem is the often lacking standardization of extracts for skin testing and for the determination of specific IgE. Some of the allergens have been characterized and few of them synthesized using recombinant techniques. Most investigations have been made with whole-body extracts or extracts from salivary glands, while desensitization has rarely been attempted. Currently, primary prevention by avoidance of stings and bites, and adequate instruction of sensitized individuals in the use of emergency drugs are mandatory.
Publication Types:
PMID: 15724094 [PubMed - indexed for MEDLINE]
Comment in:
Follow-up testing among children with elevated screening blood lead levels.
Kemper AR, Cohn LM, Fant KE, Dombkowski KJ, Hudson SR.
Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, USA. kempera@med.umich.edu
CONTEXT: Follow-up testing after an abnormal screening blood lead level is a key component of lead poisoning prevention. OBJECTIVES: To measure the proportion of children with elevated screening lead levels who have follow-up testing and to determine factors associated with such care. DESIGN, SETTING, AND PARTICIPANTS: Retrospective, observational cohort study of 3682 Michigan Medicaid-enrolled children aged 6 years or younger who had a screening blood lead level of at least 10 microg/dL (0.48 micromol/L) between January 1, 2002, and June 30, 2003. MAIN OUTCOME MEASURE: Testing within 180 days of an elevated screening lead level. RESULTS: Follow-up testing was received by 53.9% (95% confidence interval [CI], 52.2%-55.5%) of the children. In multivariate analysis adjusting for age, screening blood lead level results, and local health department catchment area, the relative risk of follow-up testing was lower for Hispanic or nonwhite children than for white children (0.91; 95% CI, 0.87-0.94), for children living in urban compared with rural areas (0.92; 95% CI, 0.89-0.96), and for children living in high- compared with low-risk lead areas (0.94; 95% CI, 0.92-0.96). Among children who did not have follow-up testing, 58.6% (95% CI, 56.3%-61.0%) had at least 1 medical encounter in the 6-month period after the elevated screening blood lead level, including encounters for evaluation and management (39.3%; 95% CI, 36.9%-41.6%) or preventive care (13.2%; 95% CI, 11.6%-14.8%). CONCLUSIONS: The rate of follow-up testing after an abnormal screening blood lead level was low, and children with increased likelihood of lead poisoning were less likely to receive follow-up testing. At least half of the children had a missed opportunity for follow-up testing. The observed disparities of care may increase the burden of cognitive impairment among at-risk children.
PMID: 15886378 [PubMed - indexed for MEDLINE]
Comment on:
Bites of the brown recluse spider.
Wasserman GS.
Publication Types:
PMID: 15892198 [PubMed - indexed for MEDLINE]
Comment on:
Bites of the brown recluse spider.
Atlas E, Yee A.
Publication Types:
PMID: 15888710 [PubMed - indexed for MEDLINE]
| Display Show |
|
|